The decision making process in women diagnosed with estrogen receptor-positive breast cancer experiencing side effects related to oral endocrine therapy
Indiana University-Purdue University Indianapolis (IUPUI) === Oral endocrine therapy (OET) is standard therapy for millions of estrogen receptor-positive breast cancer survivors (ER+BCS). OET reduces recurrence, mortality, and metastasis. ER+BCS often do not take their OET as recommended due to...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1805/12837 |